+Compare
SMLR
Stock ticker:
NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
192.87M

SMLR Semler Scientific Forecast, Technical & Fundamental Analysis

a medical risk-assessment company

GET INTRADAY SIGNALS
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for SMLR with price predictions
08:00 PM EDT Jun 01, 2023

SMLR in +2.40% Uptrend, rising for three consecutive days on June 02, 2023

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SMLR advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

SMLR moved above its 50-day moving average on May 10, 2023 date and that indicates a change from a downward trend to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 255 cases where SMLR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SMLR moved out of overbought territory on May 18, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on May 26, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on SMLR as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SMLR turned negative on May 25, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMLR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SMLR broke above its upper Bollinger Band on May 12, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SMLR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.152) is normal, around the industry mean (25.286). P/E Ratio (14.006) is within average values for comparable stocks, (143.072). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.656). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (3.674) is also within normal values, averaging (53.674).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SMLR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.42B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 1%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 22%. RSHUF experienced the highest price growth at 158%, while SQIDF experienced the biggest fall at -49%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 23%. For the same stocks of the Industry, the average monthly volume growth was 14% and the average quarterly volume growth was -77%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 62
SMR Rating: 83
Profit Risk Rating: 85
Seasonality Score: 14 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

SMLR is expected to report earnings to fall 14.29% to 54 cents per share on August 01

Semler Scientific SMLR Stock Earnings Reports
Q2'23
Est.
$0.54
Q1'23
Beat
by $0.05
Q4'22
Beat
by $0.13
Q3'22
Beat
by $0.23
Q2'22
Beat
by $0.06
The last earnings report on May 10 showed earnings per share of 62 cents, beating the estimate of 57 cents. With 39.28K shares outstanding, the current market capitalization sits at 192.87M.
A.I. Advisor
published General Information

General Information

a medical risk-assessment company

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
2340-2348 Walsh Avenue
Phone
+1 877 774-4211
Employees
127
Web
http://www.semlerscientific.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MJRFX21.260.48
+2.31%
BlackRock Mid-Cap Value K
RFIMX6.800.14
+2.10%
Ranger Micro Cap Institutional
GSGCX38.820.69
+1.81%
Goldman Sachs Equity Income C
FCEEX9.190.14
+1.55%
Franklin Emerging Market Core Equity Adv
FRIQX11.240.09
+0.81%
Fidelity Advisor® Real Estate Income M

SMLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMLR has been loosely correlated with DHR. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SMLR jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMLR
1D Price
Change %
SMLR100%
+1.85%
DHR - SMLR
34%
Loosely correlated
+0.83%
SYK - SMLR
33%
Poorly correlated
-0.10%
CHEK - SMLR
32%
Poorly correlated
+14.84%
RVTY - SMLR
32%
Poorly correlated
-0.39%
A - SMLR
32%
Poorly correlated
+1.69%
More

Groups containing SMLR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMLR
1D Price
Change %
SMLR100%
+1.85%
medical service
(undefined stocks)
35%
Loosely correlated
+1.57%
medical research
(undefined stocks)
35%
Loosely correlated
+1.67%